Humberto Scoccia, MDProfessor of Obstetrics & Gynecology, Director Division of Reproductive Endocrinology & Infertility, Medical Director University of Illinois IVF Program
Humberto “Bert” Scoccia, MD is double board-certified in Obstetrics & Gynecology, and Reproductive Endocrinology & Infertility. He is an expert in in vitro fertilization, infertility, premature ovarian insufficiency, recurrent pregnancy loss, tubal microsurgery, advanced hysteroscopy and laparoscopic surgery, ovulation induction and fertility preservation.
Dr. Scoccia is a nationally recognized infertility specialist, known for his expertise in ovulation induction, individualization of in vitro fertilization (IVF) therapy and fertility preservation.
Dr. Scoccia’s research includes optimizing ovulation induction protocols in poor responder IVF patients, optimizing the endometrial lining prior to embryo transfer in IVF patients and studying whether fertility drugs increase the risk of developing reproductive cancers in later life.
Dr. Scoccia is on the Editorial Board of the journals, Obstetrics & Gynecology and Journal of Minimally Invasive Gynecology.
Dr. Scoccia has been honored with the Physician Award of Excellence by Resolve of Illinois. He has also been awarded Best Doctors® (top 5% in the country) since 2009, Castle Connelly’s America’s Top Doctors® (top 1% in the country) since 2013, and Chicago Magazine’s Top Doctors® for Women: Reproductive Endocrinology since 2012.
Dr. Scoccia’s patient care philosophy is to provide compassionate care and to offer evidence-based individualized evaluation and management. He also believes in listening to patients’ questions and concerns in order to optimize treatment success.
Dr. Scoccia is fluent in Spanish and Italian.
Scoccia B. What is new in Polycystic Ovary Syndrome? Best articles from the past year. Obstetrics & Gynecology 2016;128:1174-1176.
Scoccia, B. What is new in assisted reproduction and multiple pregnancy reduction? Best articles from the past year. Obstetrics & Gynecology 2015;126:446-447.
Baumgarten SC, Convissar SM, Zamah AM, Fierro MA, Winston NJ, Scoccia B, Stocco C. FSH regulates IGF2 expression in human granulosa cells in an AKT-dependent manner. Journal of Clinical Endocrinology & Metabolism 2015;100:E1046-55.
Brinton LA, Moghissi KS, Scoccia B, Lamb EJ, Trabert B, Niwa S, Ruggieri D, Westhoff C. Effects of fertility drugs on cancers other than breast and gynecologic malignancies. Fertility & Sterility 2015;104:980-988.
Sam S, Scoccia B, Yalamanchi S, Mazzone T. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome. Human Reproduction 2015;30:1358-1364.
Knuttinen MG, Jajko R, Scoccia B. Fluoroscopic tubal recanalization in tubal factor related infertility. Seminars in Interventional Radiology 2014;31:269-271.
Baumgarten SC, Convissar SM, Fierro MA, Winston NJ, Scoccia B, Stocco C. IGF1R signaling is necessary for FSH-induced activation of AKT and differentiation of human cumulus granulosa cells. Journal of Clinical Endocrinology & Metabolism 2014;99:2995-3004.
Brinton LA, Scoccia B, Moghissi K, Westhoff CL, Niwa S, Britton T, Lamb E. Long-term relationships of ovulation-stimulating drugs to breast cancer risk. Cancer Epidemiology Biomarkers & Prevention 2014;23:584-593.
For a list of Dr. Scoccia’s publications, please click the following link:
Recent Abstracts & Presentations
Zamah AM, Baumgarten SC, Convissar SM, Fierro MA, Winston NJ, Stocco C, Scoccia B. “FSH regulated IGF2 expression in human granulosa cells in an AKT-dependent manner”.
Annual Meeting of the American Society for Reproductive Medicine, Baltimore MD, October 2015.
Brinton LA, Moghissi KS, Scoccia B, Lamb EJ, Britton T, Niwa S, Ruggieri D, Westhoff CL. “Effects of fertility drugs on cancers other than breast and gynecologic malignancies”. Annual Meeting of the Society for Epidemiologic Research, Denver CO, June 2015.